Position in GNLX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$19,067
-$15,084 QoQ
Shares Held
7,879
+0.6% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,945,837,016 across 415 Biotechnology names. GNLX ranks #294 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in GNLX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,067 | 7,879 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $34,151 | 7,833 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $18,677 | 4,447 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $881 | 307 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $828 | 307 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $960 | 407 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||